CLINICAL_TRIALS
trial_result
· 2020-11-24
Clinical Trial Update: Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia [Phase 2]
Summary
Phase 2 trial updates bosutinib in Japanese adults with newly diagnosed chronic phase chronic myeloid leukemia; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Leukemia, Chronic Myelogenous | Phase 2 | Status: COMPLETED | Results posted: 2020-11-24